Crane CEO Says Sale Of UK Building Services Unit Ends Its Non-Residential Construction Exposure

Alex Alcala says no more substantial divestitures are on the table, and chemical is now close to 20% of process-flow end markets, from about 30%.

Share
Crane CEO Says Sale Of UK Building Services Unit Ends Its Non-Residential Construction Exposure

Crane's planned sale of its UK building services and utilities business completes the company's exit from non-residential construction, and no other substantial divestitures are under review, CEO Alex Alcala said on the company's third-quarter earnings call Wednesday. Crane, which makes engineered components for aerospace, defense, space and process industries, also said chemical's weight in its process-flow business has shrunk to close to 20%.

No more big sales, for now

Asked by a D.A. Davidson analyst whether more consequential portfolio moves are coming at Process Flow Technologies, Alcala said: "there is no more substantial divestitures that we're looking at right now." He added that the company evaluates its portfolio every year and its thinking could change.

The UK unit follows the earlier sale of Crane's Canadian supply business. Alcala called the building services unit "a very well-run business operated by a great team, but not really aligned to the markets that we're trying to expand into."

Dilution math on the swap

Chief Financial Officer Rich Malley said the building services business should generate roughly $160 million of revenue this year at fleet-average margins. Trillium Pumps, which Crane has agreed to buy, brings $115 million of revenue at below-fleet margins, so some dilution is coming.

Malley said the company is currently thinking a close would come sometime near the end of the first quarter, so the effect is not a full-year hit. He expects Trillium to offset a good portion of it within the year.

Chemical's shrinking share

Alcala said chemical was historically about 30% of the process-flow end-market mix and is now close to 20%. Water and wastewater is around 14% to 15%, general industrial about 20%, and power, covering gas and nuclear, about 15%.

Chemical demand remains flat, he said, so any recovery would be upside: the business no longer depends on it to grow. Core orders at Process Flow Technologies rose 20% from a year earlier and 8% from the prior quarter. Malley said about 70% of Crane's chemical exposure is in the US.

On the Middle East, Alcala said exposure sits mainly in process flow and totals under 5% overall. Shipments were delayed earlier in the year, he said, but that has somewhat normalized, and he sees no material impact this year or beyond.

Raised outlook and next date

Crane raised its full-year adjusted earnings outlook by 35 cents to a range of $7.23 to $7.38 per share. Alcala said the company is "not finished" strengthening its portfolio and will hold an Investor Day on February 9 in New York City.

Crane's next scheduled checkpoint is the February 9 Investor Day in New York City.

Sources

More on Crane

All Crane (CR) coverage →